{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:01:37Z","timestamp":1792425697235,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007263","name":"Astellas Foundation for Research on Metabolic Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007263","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008667","name":"SENSHIN Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008667","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jns.2020.117217","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T23:18:55Z","timestamp":1604445535000},"page":"117217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Strategies to prevent hemorrhagic transformation after reperfusion therapies for acute ischemic stroke: A literature review"],"prefix":"10.1016","volume":"419","author":[{"given":"Yutaka","family":"Otsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Namekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Toriyabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itaru","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Shimohata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kanazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2020.117217_bb0005","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0010","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1161\/STROKEAHA.109.192535","article-title":"Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association\/American Stroke Association","volume":"40","author":"del Zoppo","year":"2009","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0015","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","article-title":"2018 guidelines for the early Management of Patients with Acute Ischemic Stroke\u202f: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"49","author":"Powers","year":"2018","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411587","article-title":"A randomized trial of intraarterial treatment for acute ischemic stroke","volume":"372","author":"Berkhemer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0025","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMoa1503780","article-title":"Thrombectomy within 8 hours after symptom onset in ischemic stroke","volume":"372","author":"Jovin","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0030","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1414905","article-title":"Randomized assessment of rapid endovascular treatment of ischemic stroke","volume":"372","author":"Goyal","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0035","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1056\/NEJMoa1415061","article-title":"Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke","volume":"372","author":"Saver","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0040","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMoa1414792","article-title":"Endovascular therapy for ischemic stroke with perfusion-imaging selection","volume":"372","author":"Campbell","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0045","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1161\/STROKEAHA.119.027921","article-title":"Trends of r-tPA (recombinant tissue-type plasminogen activator) treatment and treatment-influencing factors in acute ischemic stroke","volume":"51","author":"Marko","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0050","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.jns.2020.117217_bb0055","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1161\/STROKEAHA.115.011050","article-title":"Mechanical thrombectomy in and outside the REVASCAT trial insights from a concurrent population-based stroke registry","volume":"46","author":"Urra","year":"2015","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0060","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(10)60491-6","article-title":"Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials","volume":"375","author":"Lees","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.117217_bb0065","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S1474-4422(16)30076-X","article-title":"Risk of intracerebral haemorrhage with alteplase after acute ischaemic stroke: a secondary analysis of an individual patient data meta-analysis","volume":"15","author":"Whiteley","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0070","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1804355","article-title":"MRI\u00adguided thrombolysis for stroke with unknown time of onset","volume":"379","author":"Thomalla","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0075","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(19)31053-0","article-title":"Extending thrombolysis to 4\u00b75-9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data","volume":"394","author":"Campbell","year":"2019","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2020.117217_bb0080","doi-asserted-by":"crossref","first-page":"e1241","DOI":"10.1212\/WNL.0000000000008904","article-title":"Thrombolysis for acute ischemic stroke in the unwitnessed or extended therapeutic time window","volume":"94","author":"Tsivgoulis","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2020.117217_bb0085","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct","volume":"378","author":"Nogueira","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0090","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJMoa1713973","article-title":"Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging","volume":"378","author":"Albers","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0095","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1161\/STROKEAHA.119.028287","article-title":"The incidence and associated factors of early neurological deterioration after thrombolysis: results from SITS registry","volume":"51","author":"Yu","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0100","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1161\/STR.0000000000000152","article-title":"Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"48","author":"Yaghi","year":"2017","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp-2019-321904","article-title":"Use of MRI to predict symptomatic haemorrhagic transformation after thrombolysis for cerebral ischaemia","volume":"91","author":"Caparros","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2020.117217_bb0110","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db19-0440","article-title":"Association of baseline hyperglycemia with outcomes of patients with and without diabetes with acute ischemic stroke treated with intravenous thrombolysis: a propensity score-matched analysis from the SITS-ISTR registry","volume":"68","author":"Tsivgoulis","year":"2019","journal-title":"Diabetes."},{"key":"10.1016\/j.jns.2020.117217_bb0115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/ncn3.63","article-title":"Therapeutic strategies to attenuate hemorrhagic transformation after tissue plasminogen activator treatment for acute ischemic stroke","volume":"1","author":"Shimohata","year":"2013","journal-title":"Neurol. Clin. Neurosci."},{"key":"10.1016\/j.jns.2020.117217_bb0120","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic transformation after ischemic stroke in animals and humans","volume":"34","author":"Jickling","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2020.117217_bb0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5551\/jat.RV16006","article-title":"Therapeutic strategies to attenuate Hemorrhagic transformation after tissue plasminogen activator treatment for acute ischemic stroke","volume":"24","author":"Kanazawa","year":"2017","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.jns.2020.117217_bb0130","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00004647-199802000-00011","article-title":"Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat","volume":"18","author":"Peters","year":"1998","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2020.117217_bb0135","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1093\/brain\/awv079","article-title":"Multiple therapeutic effects of progranulin on experimental acute ischaemic stroke","volume":"138","author":"Kanazawa","year":"2015","journal-title":"Brain."},{"key":"10.1016\/j.jns.2020.117217_bb0140","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.3390\/ijms18102135","article-title":"Microglia and monocytes\/macrophages polarization reveal novel therapeutic mechanism against stroke","volume":"18","author":"Kanazawa","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2020.117217_bb0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/ene.13575","article-title":"Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study","volume":"25","author":"Shi","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0150","doi-asserted-by":"crossref","first-page":"116445","DOI":"10.1016\/j.jns.2019.116445","article-title":"Neutrophil to lymphocyte ratio predicts poor outcomes after acute ischemic stroke: a cohort study and systematic review","volume":"406","author":"Wang","year":"2019","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jns.2020.117217_bb0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.bbi.2015.06.007","article-title":"Recombinant tissue plasminogen activator promotes, and progesterone attenuates, microglia\/macrophage M1 polarization and recruitment of microglia after MCAO stroke in rats","volume":"49","author":"Won","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jns.2020.117217_bb0160","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0271678X19834158","article-title":"Angiogenesis in the ischemic core: a potential treatment target?","volume":"39","author":"Kanazawa","year":"2019","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2020.117217_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1673-5374.264442","article-title":"Angiogenesis and neuronal remodeling after ischemic stroke","volume":"15","author":"Hatakeyama","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jns.2020.117217_bb0170","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/jcbfm.2011.9","article-title":"Inhibition of VEGF signaling pathway attenuates hemorrhage after tPA treatment","volume":"31","author":"Kanazawa","year":"2011","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2020.117217_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098639","article-title":"Effects of angiopoietin-1 on hemorrhagic transformation and cerebral edema after tissue plasminogen activator treatment for ischemic stroke in rats","volume":"9","author":"Kawamura","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2020.117217_bb0180","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1161\/STROKEAHA.108.514026","article-title":"Extension of the thrombolytic time window with minocycline in experimental stroke","volume":"39","author":"Murata","year":"2008","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0185","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s12035-020-01893-7","article-title":"Tissue plasminogen activator promotes TXNIP-NLRP3 inflammasome activation after hyperglycemic stroke in mice","volume":"57","author":"Ismael","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jns.2020.117217_bb0190","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/jcbfm.2013.163","article-title":"Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway","volume":"34","author":"Won","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2020.117217_bb0195","series-title":"International Stroke Conference 2020, Los Angeles, CA, USA","article-title":"The randomized study of endovascular therapy with versus without intravenous tissue plasminogen activator in acute stroke with ICA and M1 occlusion (SKIP study)","author":"Suzuki","year":"2020"},{"key":"10.1016\/j.jns.2020.117217_bb0200","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular thrombectomy with or without intravenous alteplase in acute stroke","volume":"382","author":"Yang","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0205","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/jcbfm.2008.164","article-title":"Dissociation and protection of the neurovascular unit after thrombolysis and reperfusion in ischemic rat brain","volume":"29","author":"Yamashita","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2020.117217_bb0210","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.10.011","article-title":"Edaravone with and without .6mg\/kg alteplase within 4.5 hours after ischemic stroke: A prospective cohort study (PROTECT4.5)","volume":"26","author":"Yamaguchi","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.jns.2020.117217_bb0215","article-title":"Edaravone for acute ischaemic stroke","volume":"12","author":"Feng","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jns.2020.117217_bb0220","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMoa070240","article-title":"NXY-059 for the treatment of acute ischemic stroke","volume":"357","author":"Shuaib","year":"2007","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0225","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/STROKEAHA.116.015042","article-title":"YAMATO study (tissue-type plasminogen activator and edaravone combination therapy)","volume":"48","author":"Aoki","year":"2017","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0230","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa052643","article-title":"Oral fingolimod (FTY720) for relapsing multiple sclerosis","volume":"355","author":"Kappos","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0235","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1161\/STROKEAHA.112.679043","article-title":"Fingolimod reduces hemorrhagic transformation associated with delayed tissue plasminogen activator treatment in a mouse thromboembolic model","volume":"44","author":"Campos","year":"2013","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0240","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/ana.25352","article-title":"Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow","volume":"84","author":"Tian","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0245","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/brain\/awf133","article-title":"Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis","volume":"125","author":"Brundula","year":"2002","journal-title":"Brain."},{"key":"10.1016\/j.jns.2020.117217_bb0250","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","article-title":"Minocycline treatment in acute stroke: an open-label, evaluator-blinded study","volume":"69","author":"Lampl","year":"2007","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2020.117217_bb0255","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/0028-3886.93584","article-title":"Efficacy of minocycline in acute ischemic stroke: a single-blinded, placebo-controlled trial","volume":"60","author":"Srivastava","year":"2012","journal-title":"Neurol. India"},{"key":"10.1016\/j.jns.2020.117217_bb0260","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00415-018-8935-3","article-title":"Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials","volume":"265","author":"Malhotra","year":"2018","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0265","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.3389\/fneur.2018.01103","article-title":"Efficacy of minocycline in acute ischemic stroke: a systematic review and meta-analysis of rodent and clinical studies","volume":"9","author":"Sheng","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0270","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/356063a0","article-title":"Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin","volume":"356","author":"Yednock","year":"1992","journal-title":"Nature."},{"key":"10.1016\/j.jns.2020.117217_bb0275","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa020732","article-title":"Natalizumab for active Crohn\u2019s disease","volume":"348","author":"Ghosh","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0280","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJMoa020696","article-title":"A controlled trial of natalizumab for relapsing multiple sclerosis","volume":"348","author":"Miller","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0285","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","article-title":"Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring","volume":"10","author":"Kappos","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0290","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1474-4422(16)30357-X","article-title":"Safety and efficacy of natalizumab in patients with acute ischaemic stroke (ACTION): a randomised, placebo-controlled, double-blind phase 2 trial","volume":"16","author":"Elkins","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0295","doi-asserted-by":"crossref","first-page":"e1091","DOI":"10.1212\/WNL.0000000000010038","article-title":"Natalizumab in acute ischemic stroke (ACTION II): a randomized, placebo-controlled trial","volume":"95","author":"Elkind","year":"2020","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2020.117217_bb0300","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pbb.2011.07.018","article-title":"SP-8203 shows neuroprotective effects and improves cognitive impairment in ischemic brain injury through NMDA receptor","volume":"100","author":"Noh","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.jns.2020.117217_bb0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/ana.25644","article-title":"Safety and efficacy of otaplimastat in patients with acute ischemic stroke requiring tPA (SAFE-TPA): a multicenter, randomized, double-blind, placebo-controlled phase 2 study","volume":"87","author":"Kim","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0310","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nm1390","article-title":"Newly expressed SUR1-regulated NC(ca-ATP) channel mediates cerebral edema after ischemic stroke","volume":"12","author":"Simard","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0315","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/STROKEAHA.109.572644","article-title":"Glibenclamide is superior to decompressive craniectomy in a rat model of malignant stroke","volume":"41","author":"Simard","year":"2010","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195526","article-title":"SUR1-TRPM4 channel activation and phasic secretion of MMP-9 induced by tPA in brain endothelial cells","volume":"13","author":"Gerzanich","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2020.117217_bb0325","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1474-4422(16)30196-X","article-title":"Safety and efficacy of intravenous glyburide on brain swelling after large hemispheric infarction (GAMES-RP): a randomised, double-blind, placebo-controlled phase 2 trial","volume":"15","author":"Sheth","year":"2016","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0330","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000006618","article-title":"Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial","volume":"91","author":"Kimberly","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2020.117217_bb0335","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1471-4159.2012.07773.x","article-title":"Evidence for the efficacy of statins in animal stroke models: a meta-analysis","volume":"122","author":"Garc\u00eda-Bonilla","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jns.2020.117217_bb0340","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1212\/WNL.0000000000005907","article-title":"Association of statin use with spontaneous intracerebral hemorrhage: a cohort study","volume":"91","author":"Saliba","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2020.117217_bb0345","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s12975-014-0381-7","article-title":"Effect of simvastatin on MMPs and TIMPs in human brain endothelial cells and experimental stroke","volume":"6","author":"Reuter","year":"2015","journal-title":"Transl. Stroke Res."},{"key":"10.1016\/j.jns.2020.117217_bb0350","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2015.07.013","article-title":"Neuroprotective effects and dynamic expressions of MMP9 and TIMP1 associated with atorvastatin pretreatment in ischemia - reperfusion rats","volume":"603","author":"Fang","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.jns.2020.117217_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2019.08.074","article-title":"The effect of HMG-CoA reductase inhibitors on thrombolysis-induced haemorrhagic transformation","volume":"69","author":"Wu","year":"2019","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.jns.2020.117217_bb0360","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1161\/STROKEAHA.116.014600","article-title":"Combination of thrombolysis and statins in acute stroke is safe","volume":"47","author":"Montaner","year":"2016","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0365","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12017-007-8010-1","article-title":"Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice","volume":"9","author":"Haberman","year":"2007","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.jns.2020.117217_bb0370","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5853\/jos.2017.02901","article-title":"Neuroprotectants in the era of reperfusion therapy","volume":"20","author":"Chamorro","year":"2018","journal-title":"J. Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0375","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1161\/hs0402.105927","article-title":"Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke","volume":"33","author":"Chamorro","year":"2002","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0380","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1161\/STROKEAHA.116.014672","article-title":"Uric acid therapy prevents early ischemic stroke progression: a tertiary analysis of the URICO-ICTUS trial (efficacy study of combined treatment with uric acid and r-tPA in acute ischemic stroke)","volume":"47","author":"Amaro","year":"2016","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0385","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jama.2016.13647","article-title":"Time to treatment with endovascular thrombectomy and outcomes from ischemic stroke: a meta-analysis","volume":"316","author":"Saver","year":"2016","journal-title":"JAMA."},{"key":"10.1016\/j.jns.2020.117217_bb0390","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1161\/STROKEAHA.118.024512","article-title":"Predictors of parenchymal hematoma after mechanical thrombectomy: a multicenter study","volume":"50","author":"Boisseau","year":"2019","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0395","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147287","article-title":"Endovascular treatment with stent-retriever devices for acute ischemic stroke: a meta-analysis of randomized controlled trials","volume":"11","author":"Bush","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2020.117217_bb0400","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1161\/STROKEAHA.110.604603","article-title":"Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke","volume":"42","author":"Bang","year":"2011","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0405","first-page":"1370","article-title":"Predicting symptomatic intracranial haemorrhage after mechanical thrombectomy: the TAG score","volume":"90","author":"Montalvo","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jns.2020.117217_bb0410","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/ene.14202","article-title":"Uric acid level and risk of symptomatic intracranial haemorrhage in ischaemic stroke treated with endovascular treatment","volume":"27","author":"Yuan","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0415","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/STROKEAHA.119.026606","article-title":"Endovascular stroke treatment and risk of intracranial hemorrhage in anticoagulated patients","volume":"51","author":"Meinel","year":"2020","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0420","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1161\/STROKEAHA.117.018653","article-title":"White matter hyperintensity volume and outcome of mechanical thrombectomy with stentriever in acute ischemic stroke","volume":"48","author":"Atchaneeyasakul","year":"2017","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0425","doi-asserted-by":"crossref","first-page":"e1498","DOI":"10.1212\/WNL.0000000000008317","article-title":"White matter hyperintensity burden in patients with ischemic stroke treated with thrombectomy","volume":"93","author":"Boulouis","year":"2019","journal-title":"Neurology."},{"key":"10.1016\/j.jns.2020.117217_bb0430","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1161\/hs0901.094282","article-title":"Collateral growth and angiogenesis around cortical stroke","volume":"32","author":"Wei","year":"2001","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0435","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.STR.0000119751.92640.7F","article-title":"Appearance of early venous filling during intra-arterial reperfusion therapy for acute middle cerebral artery occlusion: a predictive sign for hemorrhagic complications","volume":"35","author":"Ohta","year":"2004","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0440","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1161\/STROKEAHA.118.021402","article-title":"Early cerebral vein after endovascular ischemic stroke treatment predicts symptomatic reperfusion hemorrhage","volume":"49","author":"Cartmell","year":"2018","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0445","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3174\/ajnr.A3044","article-title":"Hemorrhage\/contrast staining areas after mechanical intra-arterial thrombectomy in acute ischemic stroke: imaging findings and clinical significance","volume":"33","author":"Parrilla","year":"2012","journal-title":"Am. J. Neuroradiol."},{"key":"10.1016\/j.jns.2020.117217_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.24671","article-title":"Direct arterial damage and neurovascular unit disruption by mechanical thrombectomy in a rat stroke model","author":"Sasaki","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jns.2020.117217_bb0455","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2020.117217_bb0460","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1161\/STROKEAHA.116.013715","article-title":"Desmoteplase 3 to 9 hours after major artery occlusion stroke: the DIAS-4 trial (efficacy and safety study of desmoteplase to treat acute ischemic stroke)","volume":"47","author":"von Kummer","year":"2016","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2020.117217_bb0465","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1161\/STROKEAHA.110.598359","article-title":"Distinct effects of tissue-type plasminogen activator and SMTP-7 on cerebrovascular inflammation following thrombolytic reperfusion","volume":"42","author":"Miyazaki","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2020.117217_bb0470","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/jcbfm.2013.191","article-title":"SMTP-7, a novel small-molecule thrombolytic for ischemic stroke: a study in rodents and primates","volume":"34","author":"Sawada","year":"2014","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.jns.2020.117217_bb0475","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainres.2014.07.004","article-title":"SMTP-7, a new thrombolytic agent, decreases hemorrhagic transformation after transient middle cerebral artery occlusion under warfarin anticoagulation in mice","volume":"1578","author":"Ito","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.jns.2020.117217_bb0480","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.448","article-title":"Efficacy of SMTP-7, a small-molecule anti-inflammatory thrombolytic, in embolic stroke in monkeys","volume":"6","author":"Suzuki","year":"2018","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.jns.2020.117217_bb0485","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1056\/NEJMoa1716405","article-title":"Tenecteplase versus alteplase before thrombectomy for ischemic stroke","volume":"378","author":"Campbell","year":"2018","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.jns.2020.117217_bb0490","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1474-4422(17)30253-3","article-title":"Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial","volume":"16","author":"Logallo","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0495","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jama.2020.1511","article-title":"Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trial","volume":"323","author":"Campbell","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2020.117217_bb0500","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","article-title":"Ischemic stroke: experimental models and reality","volume":"133","author":"Sommer","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jns.2020.117217_bb0505","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25643","article-title":"Why Most acute stroke studies are positive in animals but not in patients: a systematic comparison of preclinical, early phase, and phase 3 clinical trials of neuroprotective agents","volume":"87","author":"Schmidt-Pogoda","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0510","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(20)30258-0","article-title":"Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial","volume":"395","author":"Hill","year":"2020","journal-title":"Lancet."},{"key":"10.1016\/j.jns.2020.117217_bb0515","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.3390\/ijms21176194","article-title":"Cell therapies under clinical trials and polarized cell therapies in pre-clinical studies to treat ischemic stroke and neurological diseases: a literature review","volume":"21","author":"Hatakeyama","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jns.2020.117217_bb0520","doi-asserted-by":"crossref","first-page":"42582","DOI":"10.1038\/srep42582","article-title":"Microglia preconditioned by oxygen-glucose deprivation promote functional recovery in ischemic rats","volume":"7","author":"Kanazawa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2020.117217_bb0525","doi-asserted-by":"crossref","first-page":"16819","DOI":"10.1038\/s41598-019-53418-5","article-title":"A novel therapeutic approach using peripheral blood mononuclear cells preconditioned by oxygen-glucose deprivation","volume":"9","author":"Hatakeyama","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2020.117217_bb0530","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S1474-4422(17)30046-7","article-title":"Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"16","author":"Hess","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jns.2020.117217_bb0535","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1161\/CIRCULATIONAHA.117.030659","article-title":"A phase 2 randomized, sham-controlled Trial of internal carotid artery infusion of autologous bone marrow-derived ALD-401 cells in patients with recent stable ischemic stroke (RECOVER-stroke)","volume":"139","author":"Savitz","year":"2019","journal-title":"Circulation."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X20305530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:54:06Z","timestamp":1758383646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X20305530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":107,"alternative-id":["S0022510X20305530"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2020.117217","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies to prevent hemorrhagic transformation after reperfusion therapies for acute ischemic stroke: A literature review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2020.117217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117217"}}